Arena Pharmaceuticals, Inc. Cash Divested from Deconsolidation
Arena Pharmaceuticals, Inc. reported Cash Divested from Deconsolidation of $406.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Cash
us-gaap:CashDivestedFromDeconsolidation · last filed 2020-02-27
- Arena Pharmaceuticals, Inc. cash divested from deconsolidation for fiscal 2017 was $406.00K.
| Period end | Cash Divested from Deconsolidation 12 month |
|---|---|
| 2017-12-31 | $406.00K 10-K · filed 2020-02-27 |